Close
Sarah Cobey

Associate Professor

Education

Affiliations

Projects

Papers

Cobey S, Larremore DB, Grad YH, Lipsitch M. (2021). Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination. Nature reviews. Immunology

Lutrick K, Ellingson KD, Baccam Z, Rivers P, Beitel S, Parker J, Hollister J, Sun X, Gerald JK, Komatsu K, Kim E, LaFleur B, Grant L, Yoo YM, Kumar A, Mayo Lamberte J, Cowling BJ, Cobey S, Thornburg NJ, Meece JK, Kutty P, Nikolich-Zugich J, Thompson MG, Burgess JL. (2021). COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research Protocol. JMIR research protocols

Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, Larremore DB. (2021). Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science (New York, N.Y.)

Holden TM, Richardson RAK, Arevalo P, Duffus WA, Runge M, Whitney E, Wise L, Ezike NO, Patrick S, Cobey S, Gerardin J. (2021). Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020. medRxiv : the preprint server for health sciences

Guthmiller JJ, Utset HA, Henry C, Li L, Zheng NY, Sun W, Costa Vieira M, Zost S, Huang M, Hensley SE, Cobey S, Palese P, Wilson PC. (2021). -Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines. mBio

Vieira MC, Donato CM, Arevalo P, Rimmelzwaan GF, Wood T, Lopez L, Huang QS, Dhanasekaran V, Koelle K, Cobey S. (2021). Lineage-specific protection and immune imprinting shape the age distributions of influenza B cases. Nature communications, 12(1)

Bloom JD, Chan YA, Baric RS, Bjorkman PJ, Cobey S, Deverman BE, Fisman DN, Gupta R, Iwasaki A, Lipsitch M, Medzhitov R, Neher RA, Nielsen R, Patterson N, Stearns T, van Nimwegen E, Worobey M, Relman DA. (2021). Investigate the origins of COVID-19. Science (New York, N.Y.), 372(6543)

Clipman SJ, Wesolowski A, Mehta SH, Cobey S, Cummings DAT, Solomon SS. (2021). Improvements in SARS-CoV-2 Testing Cascade in the US: Data from Serial Cross-sectional Assessments. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Holden TM, Richardson RAK, Arevalo P, Duffus WA, Runge M, Whitney E, Wise L, Ezike NO, Patrick S, Cobey S, Gerardin J. (2021). Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020. BMC public health, 21(1)

Cowling BJ, Lim WW, Cobey S. (2021). Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality. Nature medicine

Gostic KM, McGough L, Baskerville EB, Abbott S, Joshi K, Tedijanto C, Kahn R, Niehus R, Hay JA, De Salazar PM, Hellewell J, Meakin S, Munday JD, Bosse NI, Sherrat K, Thompson RN, White LF, Huisman JS, Scire J, Bonhoeffer S, Stadler T, Wallinga J, Funk S, Lipsitch M, Cobey S. (2020). Practical considerations for measuring the effective reproductive number, Rt. PLoS computational biology, 16(12)

Clipman SJ, Wesolowski A, Mehta SH, Agarwal S, Cobey SE, Cummings DAT, Gibson DG, Labrique AB, Kirk GD, Solomon SS. (2020). SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers. medRxiv : the preprint server for health sciences

Cobey S. (2020). Modeling infectious disease dynamics. Science (New York, N.Y.)

Caudill VR, Qin S, Winstead R, Kaur J, Tisthammer K, Pineda EG, Solis C, Cobey S, Bedford T, Carja O, Eggo RM, Koelle K, Lythgoe K, Regoes R, Roy S, Allen N, Aviles M, Baker BA, Bauer W, Bermudez S, Carlson C, Castellanos E, Catalan FL, Chemel AK, Elliot J, Evans D, Fiutek N, Fryer E, Goodfellow SM, Hecht M, Hopp K, Hopson ED Jr., Jaberi A, Kinney C, Lao D, Le A, Lo J, Lopez AG, López A, Lorenzo FG, Luu GT, Mahoney AR, Melton RL, Nascimento GD, Pradhananga A, Rodrigues NS, Shieh A, Sims J, Singh R, Sulaeman H, Thu R, Tran K, Tran L, Winters EJ, Wong A, Pennings PS. (2020). CpG-creating mutations are costly in many human viruses. Evolutionary ecology, 34(3)

Gostic KM, McGough L, Baskerville E, Abbott S, Joshi K, Tedijanto C, Kahn R, Niehus R, Hay JA, De Salazar PM, Hellewell J, Meakin S, Munday J, Bosse N, Sherratt K, Thompson RM, White LF, Huisman J, Scire J, Bonhoeffer S, Stadler T, Wallinga J, Funk S, Lipsitch M, Cobey S. (2020). Practical considerations for measuring the effective reproductive number, Rt. medRxiv : the preprint server for health sciences

Gouma S, Kim K, Weirick ME, Gumina ME, Branche A, Topham DJ, Martin ET, Monto AS, Cobey S, Hensley SE. (2020). Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility. Nature communications, 11(1)

Dugan HL, Guthmiller JJ, Arevalo P, Huang M, Chen YQ, Neu KE, Henry C, Zheng NY, Lan LY, Tepora ME, Stovicek O, Bitar D, Palm AE, Stamper CT, Changrob S, Utset HA, Coughlan L, Krammer F, Cobey S, Wilson PC. (2020). Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans. Science translational medicine, 12(573)

Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, Larremore DB. (2020). Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. medRxiv : the preprint server for health sciences

Arevalo P, McLean HQ, Belongia EA, Cobey S. (2020). Earliest infections predict the age distribution of seasonal influenza A cases. eLife, (9)

Henry C, Zheng NY, Huang M, Cabanov A, Rojas KT, Kaur K, Andrews SF, Palm AE, Chen YQ, Li Y, Hoskova K, Utset HA, Vieira MC, Wrammert J, Ahmed R, Holden-Wiltse J, Topham DJ, Treanor JJ, Ertl HC, Schmader KE, Cobey S, Krammer F, Hensley SE, Greenberg H, He XS, Wilson PC. (2019). Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. Cell host & microbe, 25(3)

Ranjeva S, Subramanian R, Fang VJ, Leung GM, Ip DKM, Perera RAPM, Peiris JSM, Cowling BJ, Cobey S. (2019). Age-specific differences in the dynamics of protective immunity to influenza. Nature communications, 10(1), https://github.com/cobeylab/Influenza-immune-dynamics/tree/master/Data

Gouma S, Zost SJ, Parkhouse K, Branche A, Topham DJ, Cobey S, Hensley SE. (2019). Comparison of human H3N2 antibody responses elicited by egg-based, cell-based, and recombinant protein-based influenza vaccines during the 2017-2018 season. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Cai FY, Fussell T, Cobey S, Lipsitch M. (2018). Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a whole-cell vaccine. PLoS computational biology, 14(10)

Wilson PC, Cobey S. (2018). Characterization of the immunologic repertoire: A quick start guide. Immunological reviews, 284(1)

Vieira MC, Zinder D, Cobey S. (2018). Selection and Neutral Mutations Drive Pervasive Mutability Losses in Long-Lived Anti-HIV B-Cell Lineages. Molecular Biology and Evolution, 35(5)

Cobey S, Grad YH. (2018). Response to Skowronski and De Serres. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 67(9)

Cobey S, Gouma S, Parkhouse K, Chambers BS, Ertl HC, Schmader KE, Halpin RA, Lin X, Stockwell TB, Das SR, Landon E, Tesic V, Youngster I, Pinsky BA, Wentworth DE, Hensley SE, Grad YH. (2018). Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 67(3)

Neu KE, Guthmiller JJ, Huang M, La J, Vieira MC, Kim K, Zheng NY, Cortese M, Tepora ME, Hamel NJ, Rojas KT, Henry C, Shaw D, Dulberger CL, Pulendran B, Cobey S, Khan AA, Wilson PC. (2019). Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination. The Journal of clinical investigation, 129(1)

Lewnard JA, Cobey S. (2018). Immune History and Influenza Vaccine Effectiveness. Vaccines, 6(2)

Wen FT, Bell SM, Bedford T, Cobey S. (2018). Estimating Vaccine-Driven Selection in Seasonal Influenza. Viruses, 10(9), https://github.com/cobeylab/flu-vaccine-sieve

Cobey S. (2018). Repeated Vaccination May Protect Children From Influenza Infection. JAMA network open, 1(6)

Cobey S, Baskerville EB, Colijn C, Hanage W, Fraser C, Lipsitch M. (2017). Host population structure and treatment frequency maintain balancing selection on drug resistance. Journal of the Royal Society, Interface, 14(133)

Cobey S. (2017). Sick if you do, sick if you don't. Nature Ecology & Evolution, 1(11)

Baskerville EB, Cobey S. (2017). Does influenza drive absolute humidity?. Proceedings of the National Academy of Sciences of the United States of America, 114(12)

Cobey S, Hensley SE. (2017). Immune history and influenza virus susceptibility. Current Opinion in Virology, (22)

Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. (2017). Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proceedings of the National Academy of Sciences of the United States of America, 114(47)

Ranjeva SL, Baskerville EB, Dukic V, Villa LL, Lazcano-Ponce E, Giuliano AR, Dwyer G, Cobey S. (2017). Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity. Proceedings of the National Academy of Sciences of the United States of America, 114(51), https://github.com/cobeylab/HPV-model

Wen F, Bedford T, Cobey S. (2016). Explaining the geographical origins of seasonal influenza A (H3N2). Proceedings. Biological sciences, 283(1838)

Lipsitch M, Barclay W, Raman R, Russell CJ, Belser JA, Cobey S, Kasson PM, Lloyd-Smith JO, Maurer-Stroh S, Riley S, Beauchemin CA, Bedford T, Friedrich TC, Handel A, Herfst S, Murcia PR, Roche B, Wilke CO, Russell CA. (2016). Viral factors in influenza pandemic risk assessment. Elife, (5)

Perron GG, Inglis RF, Pennings PS, Cobey S. (2015). Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health. Evolutionary Applications, 8(3)

Childs LM, Baskerville EB, Cobey S. (2015). Trade-offs in antibody repertoires to complex antigens. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1676)

Cobey S, Wilson P, Matsen FA 4th.. (2015). The evolution within us. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1676)

Cobey S. (2014). Pathogen evolution and the immunological niche. Annals of the New York Academy of Sciences, 1320(1)

Cobey S, Lipsitch M. (2012). Pathogen diversity and hidden regimes of apparent competition. The American naturalist, 181(1)

Cobey S, Lipsitch M. (2012). Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science (New York, N.Y.), 335(6074)

Goldstein E, Cobey S, Takahashi S, Miller JC, Lipsitch M. (2011). Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS medicine, 8(7)

Bedford T, Cobey S, Pascual M. (2011). Strength and tempo of selection revealed in viral gene genealogies. BMC evolutionary biology, (11)

Cobey S, Baskerville EB. (2010). Limits to Causal Inference with State-Space Reconstruction for Infectious Disease. PloS one, 11(12)

Bedford T, Cobey S, Beerli P, Pascual M. (2010). Global migration dynamics underlie evolution and persistence of human influenza A (H3N2). PLoS pathogens, 6(5)

Cobey S, Pascual M. (2011). Consequences of host heterogeneity, epitope immunodominance, and immune breadth for strain competition. Journal of theoretical biology, 270(1)

Cobey S, Pascual M, Dieckmann U. (2010). Ecological factors driving the long-term evolution of influenza's host range. Proceedings. Biological sciences, 277(1695)

Cobey S, Koelle K. (2008). Capturing escape in infectious disease dynamics. Trends in ecology & evolution, 23(10)

Koelle K, Cobey S, Grenfell B, Pascual M. (2006). Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science (New York, N.Y.), 314(5807)

If you’d like to update your profile, please email modifications to questions@midasnetwork.us.